Bone Biologics (BBLG) Long-Term Debt Issuances (2014 - 2021)
Bone Biologics (BBLG) reported Long-Term Debt Issuances of $276706.0 for Q3 2021, up 269.97% year-over-year from $74791.0 in Q3 2020, and down 51.39% quarter-over-quarter from $569254.0 in Q2 2021.
Bone Biologics (BBLG) Long-Term Debt Issuances (2014 - 2021) Analysis & Trends
Bone Biologics (BBLG) has 6 years of Long-Term Debt Issuances data on file, last reported at $276706.0 in Q3 2021.
- Long-Term Debt Issuances for Q3 2021 came in at $276706.0, up 269.97% year-over-year; the trailing twelve-month figure through Dec 2024 was $845960.0 (changed N/A YoY), and the FY2024 annual result was $1.8 million, changed N/A from the prior year.
- Long-Term Debt Issuances fell to $276706.0 in Q3 2021 per BBLG's latest filing, from $569254.0 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $2.0 million in Q1 2017 and troughed at $74791.0 in Q3 2020.
- A 4-year average of $497530.5 and a median of $276706.0 in 2021 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2020 and 2021: Long-Term Debt Issuances tumbled 92.34% in 2020, then jumped 643.15% in 2021.
- A 4-year view of Long-Term Debt Issuances shows it stood at $700000.0 in 2017, then slumped by 82.86% to $120000.0 in 2019, then fell by 6.15% to $112623.0 in 2020, then jumped by 145.69% to $276706.0 in 2021.
- Business Quant data shows BBLG's Long-Term Debt Issuances at $276706.0 in Q3 2021, $569254.0 in Q2 2021, and $209757.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 276,706.00 |
| Sep 30, 2021 | 276,706.00 |
| Jun 30, 2021 | 569,254.00 |
| Jun 30, 2021 | 569,254.00 |
| Mar 31, 2021 | 209,757.00 |
| Mar 31, 2021 | 209,757.00 |
| Dec 31, 2020 | 112,623.00 |
| Dec 31, 2020 | 112,623.00 |
| Sep 30, 2020 | 74,791.00 |
| Sep 30, 2020 | 74,791.00 |
| Jun 30, 2020 | 76,600.00 |
| Jun 30, 2020 | 76,600.00 |
| Mar 31, 2020 | 128,165.00 |
| Mar 31, 2020 | 128,165.00 |
| Dec 31, 2019 | 120,000.00 |
| Dec 31, 2019 | 120,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2019 | 1.00 Mn |
| Jun 30, 2019 | 1.00 Mn |